Here we focus on the interaction between body mass index (BMI, non-obese versus obese) and alternative schedule activity of exemestane assessed by measuring drug concentrations, estradiol, estrogen, sex hormone binding globulin (SHBG), androstenedione, testosterone, breast cancer tissue Ki-67, adipokines, and insulin sensitivity markers. The gene discussed is SHBG; the disease is breast carcinoma.